About Amelia Zellander
Amelia Zellander is co-founder and CSO of BioLattice Ophthalmics in Philadelphia. The company develops CorneaClear, an engineered cornea that serves as a substitute for donor cornea tissue. She is also a director of the company.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Amelia Zellander in the role, so the role may have started earlier or lasted longer.
BioLattice Ophthalmics, Inc, Current
Co-Founder & CSO, director
2026 – Present · Philadelphia, PA
BioLattice is building an engineered cornea that surgeons can implant like donor tissue, aimed at patients waiting for a transplant.
Key Colleagues at Startups
The people Amelia Zellander works with at each company, as listed on that company's latest Form D.
BioLattice Ophthalmics, Inc, · Form D/A, Oct 28, 2026
Linda Alunkal
Co-Founder & CEO, director
GJ
Gregory Jackson
Director